Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0500
-0.0050 (-10.00%)
Feb 9, 2026, 3:55 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 13.47 million as of February 9, 2026. Its market cap has increased by 292.70% in one year.
Market Cap
13.47M
Enterprise Value
8.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 17.41M to 13.47M, a decrease of -22.62%. That is a compound annual growth rate of -3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 13.47M | 11.11% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 20.13M |
| Rapid Dose Therapeutics | 19.60M |
| Hemostemix | 17.57M |
| Britannia Life Sciences | 16.23M |
| Innovotech | 14.04M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 10.34M |
| Glow Lifetech | 9.98M |